PharmaCielo Balance Sheet

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.29	0.15	0.06	0.17	5.34
Short-Term Investments	-	-	-	0.15	0.29
Cash & Short-Term Investments	0.29	0.15	0.06	0.33	5.63
Cash Growth	95.51%	137.92%	-80.93%	-94.21%	-36.97%
Accounts Receivable	0.24	0.34	0.23	0.61	0.28
Inventory	1.72	1.5	2.31	2.13	2.28
Other Current Assets	1.41	0.44	0.72	0.95	1.01
Total Current Assets	3.66	2.44	3.33	4.02	9.2
Net Property, Plant & Equipment	4.91	15.73	18.71	20.62	26.12
Long-Term Investments	-	0.23	0.21	0.2	0.64
Other Long-Term Assets	-	-	0.04	0.27	-
Total Assets	8.56	18.39	22.29	25.12	35.96
Accounts Payable	5.25	5.36	5.63	6.11	7.73
Current Portion of Long-Term Debt	18.65	15.85	15.71	0.55	0.08
Current Portion of Leases	-	-	0.04	0.27	0.15
Other Current Liabilities	0.03	0.03	0.03	0.03	0.11
Total Current Liabilities	23.92	21.23	21.42	6.95	8.07
Long-Term Debt	-	4.68	2.55	11.73	7.14
Long-Term Leases	-	-	-	0.04	1.06
Other Long-Term Liabilities	-	-	-	-	0.36
Total Long-Term Liabilities	-	4.68	2.55	11.77	8.56
Total Liabilities	23.92	25.91	23.97	18.72	16.63
Common Stock	168.15	167.01	165.99	161.71	156.34
Additional Paid-in Capital	38.13	39.5	36.41	35.79	37.09
Accumulated Other Comprehensive Income	-9.28	-6.18	-5.36	-8.69	-6.21
Retained Earnings	-212.36	-207.85	-198.71	-182.41	-167.9
Shareholders' Equity	-15.35	-7.52	-1.68	6.39	19.33
Total Liabilities & Equity	8.56	18.39	22.29	25.12	35.96
Total Debt	18.65	20.52	18.31	12.59	8.43
Net Cash (Debt)	-18.36	-20.38	-18.25	-12.26	-2.8
Net Cash Per Share	-0.10	-0.12	-0.11	-0.08	-0.02
Book Value	-15.35	-7.52	-1.68	6.39	19.33
Book Value Per Share	-0.08	-0.04	-0.01	0.04	0.13
Tangible Book Value	-15.35	-7.52	-1.68	6.39	19.33
Tangible Book Value Per Share	-0.08	-0.04	-0.01	0.04	0.13